← Evidence map

ArticleNeurological research and practice2025

Use of cannabidiol for off-label treatment of patients with refractory focal, genetic generalised and other epilepsies.

Marie Hollander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40696489